No Data
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Baolingbao (002286.SZ): Products such as red clover alcohol and maltodextrin with pharmaceutical excipient qualifications have been expanded for use in the pharmaceutical field.
Gelonghui November 4th | baolingbao (002286.SZ) stated on the investor interaction platform that, at present, the company has expanded the application of erythritol and maltodextrin with pharmaceutical excipients qualifications in the pharmaceutical field.
Bowling Bao: Report for the third quarter of 2024
Baolingbao (002286.SZ) released its performance for the first three quarters, with a net income of 0.101 billion yuan, a year-on-year increase of 119.78%.
Baolingbao Biology (002286.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 1...
Baolingbao Biology (002286.SZ): The net income in the first three quarters was 0.101 billion yuan, a year-on-year increase of 119.78%.
On October 29th, 2024, Baolingbao Biology (002286.SZ) released its third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 1.833 billion yuan, a decrease of 6.70% year-on-year; net income attributable to shareholders of the listed company was 0.101 billion yuan, an increase of 119.78% year-on-year; net income after deducting non-recurring gains and losses was 95.5896 million yuan, an increase of 215.92% year-on-year; basic earnings per share were 0.27 yuan per share.
Baolingbao Biology Ties Up With Qingdao Haizhiyuan Life Science On Food Oil Development, Sales
Pinning Down Baolingbao Biology Co.,Ltd.'s (SZSE:002286) P/E Is Difficult Right Now
No Data
No Data
